Mixing Pens and the Future of Diabetes Drugs.
J Diabetes Sci Technol · 2015
Last updated 2026-05-28| Journal | J Diabetes Sci Technol, 2015 |
|---|---|
| Citations | 2 |
| Relative citation ratio | 0.08 |
| NIH percentile | 6 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens.
Verbatim abstract via PubMed 25944896 ↗